Editor & Writer, Informa Business Intelligence, writing for The Pink Sheet, Scrip and sister publications.

Search Tweets

Twitter Feed

@stenstovall — 485 followers, 105 tweets

Shire UK Manager refers to new report showing UK lags Europe's top 5 markets in orphan drug approvals and access; calls for revamp.
Orphan drugs "are falling through the cracks" of the UK approval and access process - Shire UK manager tells seminar.
Shire UK manager says NICE £20m spend cap per therapy will "make situation worse" for orphan drug access in the UK.
Stada says Advent made €3.6bn takeover offer for the German generics maker at €58 per share. Will Cinven follow? See my Feb 13 Scrip story.
"Wellcome Trust will be playing a significant role in the future on drug resistant infection," charity's Ed Whiting tells "The Pink Sheet".
Show More